Blockchain Patent Filed By Pharmaceutical Giant Merck & Co.br>
A patent seeking to claim a blockchain solution for finding counterfeit drugs in the supply chain has been filed by pharmaceutical giant Merck & Co.
Submitted in December 2016 and published late last week, the patent application outlines a method by which a blockchain could be used to store information about a physical object and track its progress through the supply chain. The authenticity would then be stored and verified.
While Merck and many other pharma manufacturers already have systems in place to prevent knock-offs, the blockchain technology would bring new methods and likely eliminate some inefficiencies in the existing system.
Merck’s filing claims to seek “a secure, reliable storage of the reading results with very high data integrity, such that it is essentially impossible to manipulate or erase or otherwise tanper with or lose such data, e.g. due to unintended or deliberate deletion or due to data corruption.
“Furthermore, the stored information can be accessed wherever access to the blockchain is available. This allows for a safe and distributed storage and access to the stored reading results, e.g. for integrity verification purposes such as checking whether a supplier of a product being marked with a composite security marking, as described herein, was in fact the originator of the product, or not.”